Yahoo Web Search

Search results

  1. People also ask

  2. Sep 11, 2023 · On September 11, 2023, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine to include the 2023-2024 formula. The...

  3. Aug 23, 2021 · Post. For Immediate Release: August 23, 2021. Español. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech...

  4. This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty®, a messenger RNA (mRNA) based vaccine against coronavirus disease (COVID-19). This document has been updated in English: version 03 June 2022.

  5. Aug 23, 2022 · Pfizer-BioNTech COVID-19 Vaccine is FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. Pfizer-BioNTech COVID-19 Vaccine is FDA authorized to provide:

  6. www.fda.gov › vaccines-blood-biologics › comirnatyCOMIRNATY | FDA

    Aug 29, 2022 · COMIRNATY is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...

  7. Oct 20, 2021 · Comirnaty is the brand name for Pfizer's coronavirus vaccine. The FDA approved the shot in late August for Americans ages 16 and older. But posts claiming Comirnaty is not yet available...

  8. Now that the FDA-authorized Pfizer-BioNTech COVID-19 vaccine has been approved by the FDA for individuals 16 years of age and older, it will be marketed as COMIRNATY. The use of the name Pfizer-BioNTech will still be used for individuals 12-15 years old since this age group has not been approved.

  1. People also search for